Related Experiment Videos
Optimisation of mammographic breast cancer screening using a computer simulation model
1TNO Centre for Radiological Protection and Dosimetry, Arnhem, The Netherlands.
European Journal of Radiology
|February 1, 1997
Summary
Optimizing breast cancer screening protocols involves balancing risks and benefits. Realistic screening ages are 40-80 years, with increased frequency significantly reducing mortality, especially in younger women.
Area of Science:
- Medical Imaging
- Public Health
- Oncology
Background:
- Breast cancer screening protocols require optimization to maximize benefits while minimizing risks.
- Risk-benefit analyses are crucial for evaluating the effectiveness of screening programs.
Purpose of the Study:
- To analyze the risk (induction of fatal tumors) versus benefit (reduction in fatal tumors) of breast cancer screening.
- To evaluate the influence of various screening parameters on breast cancer mortality.
Main Methods:
- Utilized the Model for evaluation of Breast cancer Screening (MBS) for a simulated Swedish female population.
- Analyzed parameters including screening start/stop ages, interval frequency, tumor detection limits, and average glandular dose.
Main Results:
- Screening between ages 40 and 80 appears realistic for reducing fatal breast tumors.
- Increased screening frequency significantly reduces mortality, particularly for ages 40-51, with marginal benefits after 70.
- Higher resolution screening (smaller tumor detection) increases benefits but doesn't alter optimal starting age.
Conclusions:
- Optimal breast cancer screening protocols involve careful consideration of age ranges and screening frequency.
- Screening effectiveness varies by age group, with greater mortality reduction in younger to middle-aged women.
- Average glandular dose primarily impacts screening risks, allowing for separate risk-benefit calculations.